Exposure-Response Analysis of Rilotumumab in Gastric Cancer: The Role of Tumour MET Expression

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2014.649
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Rilotumumab Exposure-Response Relationship in Patients With Advanced or Metastatic Gastric Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review With Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

The Expression of the PI3K/AKT/mTOR Pathway in Gastric Cancer and Its Role in Gastric Cancer Prognosis

OncoTargets and Therapy
OncologyPharmacology
2015English

Expression of DNA Damage Response Proteins in Gastric Cancer: Comprehensive Protein Profiling and Histological Analysis

International Journal of Oncology
Cancer ResearchOncology
2018English

MET Mutation and Familial Gastric Cancer

Journal of Medical Genetics
Genetics
2001English

The Tumour Suppressor miR-34c Targets MET in Prostate Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2013English

Circulating Tumour Cells Predict Survival in Gastric Cancer Patients: A Meta-Analysis

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2015English

Expression Profile and Prognostic Role of Sex Hormone Receptors in Gastric Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

MET in Gastric Cancer - Discarding a 10% Cutoff Rule

Histopathology
MedicineForensic MedicinePathologyHistology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy